News

How is Europe's opioid market evolving? What substances are causing the most concern today? How are countries responding to cannabis use? Find out more when the European Monitoring Centre for Drugs and...

Today, the 59th meeting of the EMCDDA Scientific Committee drew to a close and we said farewell and a heartfelt thank you to its members. For three decades, the Scientific Committee has...

Message from the Director 1/2024 I am delighted to announce today the publication of the latest EMCDDA work programme, which outlines our activities for 2024–2026 . This programme represents a milestone in...

As the curtain falls on 2023, we look back on a year steeped in significance for the EMCDDA. While we commemorated 30 years since the agency's creation, we also prepared for a...

Registration opens today for the next European Conference on Addictive Behaviours and Dependencies (Lisbon Addictions 2024) taking place in Lisbon from 23–25 October 2024. The multidisciplinary event will showcase cutting-edge scientific research...

EMCDDA Director Alexis Goosdeel is at the European Parliament today where he will be presenting the European Drug Report 2023: Trends and Developments (EDR 2023) to members of the Committee for Civil...

This week, the EMCDDA has launched a call to scientists interested in applying to be on a list of experts who may assist the European Union Drugs Agency (EUDA) in the risk...

Today, the EMCDDA has launched a call for expression of interest in membership of the Scientific Committee of the European Union Drugs Agency (EUDA) . The EUDA, which will replace the EMCDDA...

Representatives of the European Parliament are visiting the EMCDDA this week to discuss how the agency will adapt to its new mandate in 2024. New legislation published on 30 June grants the...

We are delighted to announce that our colleague Laurent Laniel has been presented with the medal of excellence of the Maritime Analysis and Operations Centre-Narcotics (MAOC (N)) . He received the award...

In celebration of the European Day of Languages , we are delighted to unveil the online EMCDDA multilingual glossary of drug-related terms , a practical resource aimed at ensuring high-quality and comparable...

New legislation published today grants Europe stronger powers to tackle current and future drug problems. The new Regulation of the European Parliament and of the Council , revises the mandate of the...

‘ People first: stop stigma and discrimination, strengthen prevention ’, is the theme of the 2023 International Day against Drug Abuse and Illicit Trafficking (#WorldDrugDay). The EMCDDA will mark this occasion with...

2022 was a year of solid progress for the EMCDDA as it advanced with designing and delivering more innovative and faster services to its key customers. It was also a year of...

How many new drugs were detected in Europe over the last year? What are the latest trends in drug production and trafficking? What substances are causing the most concern today? Find out...

I was very pleased to learn that the World Health Organization ( WHO ) declared this month that COVID-19 no longer constitutes a global health emergency. This is positive news for all...

The EMCDDA would like to offer its warmest congratulations to former colleague Julián Vicente who has been awarded with the Spanish Cruz Blanca de la Orden al Mérito del Plan Nacional sobre...

(20.03.2023) EMCDDA Director Alexis Goosdeel starts an official three-day visit to Austria today where he will meet with high-level officials including the Minister of Health, Johannes Rauch, and Minister of Justice, Dr...

An EMCDDA delegation is attending the sixty-sixth session of the Commission on Narcotic Drugs (CND) in Vienna this week (13-17 March), where it is providing technical support to the European Commission and...

The EMCDDA Scientific Committee , meeting in Lisbon this week, re-elected its Chair and Vice Chair and welcomed four new members. Chair Prof. Dr. Catherine Comiskey (Ireland) and Vice-Chair Prof. Dr. Henri...